| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10032510 | American Journal of Obstetrics and Gynecology | 2005 | 6 Pages |
Abstract
Overexpression of HER2/neu in uterine serous papillary endometrial cancer is an independent variable that is associated with poor outcome, occurs more frequently in black women, and may contribute to racial disparity in survival. HER2/neu expression may guide clinical treatment of patients with uterine serous papillary endometrial cancer and may have implications for the implementation of novel treatment strategies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alessandro D. MD, Stefania PhD, Eric R. MS, Michela MS, Maria MD, Martin J. PhD, Helen H. MD, Juan J. MD, Alexander MD, Sergio MD,